期刊文献+

心肌干细胞和骨髓间充质干细胞改进心肌梗死大鼠室颤阈值和心电生理稳定性的对比研究 被引量:3

The comparison of cardiac stem cells and mesenchymal stem cells transplantation in improving the ventricular fibrillation threshold and electrophysiological stability in rats with myocardial infarction
原文传递
导出
摘要 目的 比较心肌干细胞(cardiac stem cells,CSCs)和骨髓间充质干细胞(mesenchymal stem cells,MSCs)对心肌梗死(myocardial infarction,MI)大鼠室颤阈值和心电生理学稳定性的影响.方法 通过开胸结扎30只SD大鼠左前降支冠状动脉建立心肌梗死模型,2周后随机(随机数字法)分为CSCs组、MSCs组及PBS组,每组各10只,分别于局部梗死心肌内注射PKH26荧光标记的CSCs、MSCs或等量PBS.治疗6周后,再次开胸检测梗死边缘区的心电生理特性和室颤阈值.实验结束后,摘取心脏行病理切片,检查PKH26标记的CSCs、MSCs是否在梗死边缘区内生存并表达连接蛋白43.结果 CSCs组移植6周后其梗死边缘区单极电图激动恢复时间、纠正的激动恢复时间与MSCs组及对照组比较,差异无统计学意义(P>0.05);CSCs组梗死边缘区单极电图纠正的激动恢复时间离散度、电刺激所激发的恶性心律失常及室颤阈值与MSCs组及对照组比较,差异具有统计学意义(P<0.05);在上述指标方面,MSCs组和PBS组比较,均差异无统计学意义(P>0.05).PKH26标记的CSCs在梗死边缘区内被发现并表达连接蛋白43,而PKH26标记的存在于梗死边缘区的MSCs则很少表达连接蛋白43.结论 CSCs移植和MSCs移植治疗心肌梗死是比较安全有效的,无明显致心律失常性.CSCs移植后6周其心电生理学稳定性改善和室颤阈值提高的效应较MSCs优越,CSCs是治疗心血管疾病较为理想的种子细胞. Objective To compare the effects of cardiac stem cells (CSCs) versus mesenchymal stem ceils (MSCs) transplantation on the electrophysiological stability and ventricular fibrillation threshold (VFT) in rats with myocardial infarction (MI).Methods In 30 Sprague-Dawley rats,the left anterior descending coronary artery ligation was carried out to induce MI.Two weeks later,animals were randomly (random number) divided into three groups:CSCs group (n =10),MSCs group (n =10) and phosphate buffer solution (PBS) group (control group,n =10).Rats of each group was received the injection of CSCs labeled with PKH26 (fluorescent stain) in PBS or MSCs labeled with PKH26 in PBS or PBS alone into the local infarct zone.Six weeks after the intervention,the electrophysiological characteristics and VFT were measured at the infarct marginal zone.Labeled CSCs and MSCs were detected and the expression of connexin-43 was examined in 5 μm cryostat sections from each harvested heart,respectively.Results Compared with the MSCs group,there were no significant differences in the unipolar electrogram activation recovery time (ART) and the correct ART (ARTc) in the infarct marginal zone in the CSCs group six weeks after cells transplantation (P 〉 0.05);there were significant differences in the ARTc dispersion,induced refratory ventricular arrhythmias and VFT in the CSCs group compared with the MSCs group and PBS group (P〈0.05);there were no obvious differences in above findings between the MSCs group and PBS group (P 〉0.05).Labeled CSCs with PKH26 were identified in the infarct marginal zone and expressed as connexin-43.The PKH26 labeled MSCs were identified in the infarct marginal zone and rarely expressed as connexin-43.Conclusions Both CSCs and MSCs were safe and available for the treatment of myocardial infarction,also exerted as non-arrhythmogenic agents.CSCs were superior to MSCs in modulating the electrophysiological stability and improving the VFT six weeks after the cells transplantation.CSCs were ideal seed cells in the treatment of cardiovascular disease.
出处 《中华急诊医学杂志》 CAS CSCD 北大核心 2015年第9期981-986,共6页 Chinese Journal of Emergency Medicine
基金 国家自然科学基金(81270213,81070125) 广东省科技计划项目(20108031600032,2014A020211002) 高校基本科研业务费中山大学青年教师重点培育项目(13ykzd16)
关键词 心肌干细胞 骨髓间充质干细胞 心电生理学特性 室颤阈值 心肌梗死 Cardiac stem cells Mesenchymal stem cells Electrophysiological stability Fibrillation threshold Myocardial infarction
  • 相关文献

参考文献26

  • 1Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration [ J ]. Cell, 2003, 114 (6): 763-776.
  • 2Zhang H, Wang H, Li N, et al. Cardiac progenitor/stem cells on myocardial infarction or ischemic heart disease: what we have known from current research [ J]. Heart Fail Rev, 2014, 19 (2) : 247-258.
  • 3Hong KU, Bolli R. Cardiac stem cell therapy for cardiac repair [J]. Curr Treat Options Cardiovase Med, 2014, 16 (7) : 324.
  • 4Hou J, Wang L, Jiang J, et al. Cardiac Stem Cells and their Roles in Myocardial Infarction [J].Stem Cell Rev Rep, 2013, 9 (3) : 326-338.
  • 5Ye J, Yeghiazarians Y. Cardiac stem cell therapy: review of the native cardiac progenitor cells and future direction [ J ]. J Cardiovase Pharmacol, 2014, 63 (2): 85-94.
  • 6Bolli R, Tang XL, Sanganalmath SK, et al. Intraeoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemie eardiomyopathy [ J ]. Circulation, 2013, 128 (2): 122-131.
  • 7Hong KU, Guo Y, Li QH, et al. c-kit + Cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart [J]. PLoS One, 2014, 9 (5): e96725.
  • 8Malliaras K, Makkar RR, Smith RR, et al. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial ( CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction) [J]. J Am Coil Cardiol, 2014, 63 (2): 110-122.
  • 9Marbdn E, Cingolani E. Heart to heart: cardiospheres for myocardial regeneration [ J ]. Heart Rhythm, 2012, 9 (10) : 1727-1731.
  • 10王彤,郑韶欣,周长青,翁胤仑,温主治,黄辉,王景峰.心肌干细胞移植可改进心力衰竭大鼠室颤阈值和电生理的稳定性[J].中国组织工程研究与临床康复,2011,15(36):6753-6756. 被引量:6

二级参考文献23

  • 1Herrmann JL,Abarbanell AM,Weil BR,et al.Cell-based therapy for ischemic heart disease:a clinical update.Ann Thorac Surg.2009;88:1714-1722.
  • 2LaPar DJ,Kron IL,Yang Z.Stem cell therapy for ischemic heart disease:where are we? Curr Opin Organ Transplant.2009;14:79-84.
  • 3Menasché P.Cell therapy:results in cardiology.Bull Acad Natl Med.2009;193:559-568.
  • 4Schachinger V,Erbs S,Elsasser A,et al.Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.N Engl J Med.2006;355:1210-1221.
  • 5Bearzi C,Rota M,Hosoda T,et al.Human cardiac stem cells.Proc Natl Acad Sci USA.2007;104:14068-14073.
  • 6Leri A,Kajstura J,Anversa P.Cardiac stem cells and mechanisms of myocardial regeneration.Physiol Rev.2005;85:1373-1416.
  • 7Tang XL,Rokosh G,Sanganalmath SK,et al.Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction.Circulation 2010; 121(2):293-305.
  • 8Menasché P.Stem cell therapy for heart failure:are arrhythmias a real safety concern? Circulation.2009; 119:2735-2740.
  • 9Wang T,Tang W,Sun S,et al.Intravenous infusion of bone marrow mesenchymal stem cells improves myocardial function in a rat model of myocardial ischemia.Crit Care Med.2007; 35:2587-2593.
  • 10Wang T,Tang W,Sun S,et al.Mesenchymal stem cells improve outcomes of cardiopulmonary resuscitation in myocardial infarcted rats.J Mol Cell Cardiol.2009; 46:378-384.

共引文献5

同被引文献33

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部